Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
BE.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.44ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.3.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2 (Omicron)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.66ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.3.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BA.5.2.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-10155.5China
BA.2.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5 (Omicron)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BR.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used